What Researchers Did
Researchers evaluated the effects of hyperbaric oxygenation (HBO) during pregnancy, delivery, and puerperium in 150 patients with acquired and congenital heart diseases.
What They Found
They found that HBO was efficient in reducing cardiologic, obstetric, and perinatal complications among the 150 patients studied. Maternal and perinatal mortality in patients with heart disease was decreased by HBO, particularly when used as an adjunct intervention.
What This Means for Canadian Patients
Hyperbaric oxygenation could potentially reduce complications and mortality for Canadian pregnant patients with heart conditions. This suggests a potential adjunctive therapy to improve outcomes for both mothers and babies in Canada.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The abstract does not detail specific study limitations, such as the absence of a control group or comprehensive statistical data.